Lenalidomide as Salvage Therapy After Allo-SCT for Multiple Myeloma Is Effective and Leads to an Increase of Activated NK (NKp44+) and T (HLA-DR+) Cells

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2009.155